Hypoxia and Medicine

Hypoxia Cause Erythropoietin News

Reportlinker Adds Neuroprotection - Drugs, Markets and CompaniesTuesday, November 9, 2010 @ 1:28PMReportlinker.com announces that a new market research report is available in its catalogue:

Palkion Selects Novel Oral Development Candidate for the Treatment of AnemiaMonday, June 29, 2009 @ 5:00AMPalkion, Inc. announced today that it has initiated preclinical development studies for its orally available anemia therapeutic candidate that modulates the Hypoxia-Inducible Factor Prolyl Hydroxylase enzyme system.